Syndax Pharmaceuticals
Syndax Pharmaceuticals

Syndax Pharmaceuticals

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Syndax Pharmaceuticals Careers, Jobs, and Salary Information

Find High Paying Jobs and Compensation Information at Syndax Pharmaceuticals

Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The company's lead product candidate, entinostat, is a selective HDAC inhibitor that has been evaluated in multiple clinical trials in combination with immune checkpoint inhibitors and targeted therapies. Syndax is also developing SNDX-5613, a highly selective and potent inhibitor of the Menin-MLL interaction, for the treatment of acute leukemias. The company is committed to improving the lives of cancer patients through the discovery and development of novel therapies.

Snapshot

Employees59
Market Cap$1.6 billion
Revenue$1.5 million
5 Year Trendarrow trend up+158.1%
Net Income-$73.1 million
NASDAQSNDX
Founded2005
pie chartAnnual Report
stats icon
Total value of jobs:
$8,774,500
stats icon
Total Jobs:
31
stats icon
Average Pay:
$132,946